The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Zhao Baiteng | Director | Grant(A) | 38K | — | $0 |
| Jun 12, 2026 | Maroun Richard E | Director | Grant(A) | 38K | — | $0 |
| Jun 12, 2026 | Hirmand Mohammad | Director | Grant(A) | 38K | — | $0 |
| Jun 12, 2026 | Castelein Caley | Director | Grant(A) | 38K | — | $0 |
| Jun 12, 2026 | Aghazadeh Behzad | Director, 10% Owner | Grant(A) | 38K | — | $0 |
| Jun 12, 2026 | Reeve Emma | Director | Grant(A) | 38K | — | $0 |
| Jun 12, 2026 | Desai Neil | Director | Grant(A) | 38K | — | $0 |
| May 14, 2026 | Ball Bryan | See remarks | Grant(A) | 51K | $3.92 | $200K |
| May 14, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Grant(A) | 38K | $3.92 | $150K |
| May 14, 2026 | Castelein Caley | Director | Grant(A) | 255K | $3.92 | $1000K |
| May 14, 2026 | Castelein Caley | Director | Grant(A) | 2.1M | $8,124,996.24 | $16.8T |
| May 14, 2026 | Dugan Margaret | Chief Medical Officer | Grant(A) | 19K | $3.92 | $75K |
| May 14, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 51K | $3.92 | $200K |
| May 12, 2026 | Avoro Capital Advisors LLC | Director, 10% Owner | Grant(A) | 6.4M | $3.92 | $25.0M |
| Apr 16, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Sell(S) | 142K | $4.13 | $585K |
| Apr 15, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Sell(S) | 77K | $3.86 | $297K |
| Apr 14, 2026 | Ball Bryan | See remarks | Sell(S) | 92K | $3.64 | $337K |
| Apr 13, 2026 | Ball Bryan | See remarks | Sell(S) | 26K | $3.46 | $91K |
| Apr 10, 2026 | Ball Bryan | See remarks | Sell(S) | 7K | $3.43 | $23K |
| Apr 9, 2026 | Ball Bryan | See remarks | Sell(S) | 50K | $3.57 | $179K |
| Apr 9, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Sell(S) | 15K | $3.38 | $49K |
| Apr 8, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Sell(S) | 64K | $3.40 | $217K |
| Apr 7, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Sell(S) | 94K | $3.43 | $323K |
| Apr 6, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Sell(S) | 102K | $3.51 | $359K |
| Apr 2, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Sell(S) | 27K | $3.48 | $93K |
| Apr 1, 2026 | Ball Bryan | See remarks | Option exercise(M) | 367K | — | — |
| Apr 1, 2026 | Ball Bryan | See remarks | Option exercise(M) | 367K | — | $0 |
| Apr 1, 2026 | Ball Bryan | See remarks | Grant(A) | 250K | — | $0 |
| Apr 1, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 776K | — | — |
| Apr 1, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 776K | — | $0 |
| Apr 1, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 831K | — | $0 |
| Apr 1, 2026 | Dornan David | Chief Scientific Officer | Grant(A) | 282K | — | $0 |
| Apr 1, 2026 | Dugan Margaret | Chief Medical Officer | Grant(A) | 283K | — | $0 |
| Apr 1, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Option exercise(M) | 474K | — | — |
| Apr 1, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Option exercise(M) | 474K | — | $0 |
| Apr 1, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Grant(A) | 301K | — | $0 |
| Mar 2, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Sell(S) | 3K | $3.31 | $9K |
| Mar 2, 2026 | Ball Bryan | See remarks | Sell(S) | 2K | $3.31 | $6K |
| Mar 2, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Sell(S) | 5K | $3.31 | $17K |
| Mar 1, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Option exercise(M) | 7K | — | — |
| Mar 1, 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Option exercise(M) | 7K | — | $0 |
| Mar 1, 2026 | Ball Bryan | See remarks | Option exercise(M) | 5K | — | — |
| Mar 1, 2026 | Ball Bryan | See remarks | Option exercise(M) | 5K | — | $0 |
| Mar 1, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 16K | — | — |
| Mar 1, 2026 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 16K | — | $0 |
| Dec 1, 2025 | Dugan Margaret | Chief Medical Officer | Grant(A) | 55K | — | $0 |
| Dec 1, 2025 | Dugan Margaret | Chief Medical Officer | Grant(A) | 650K | — | $0 |
| Jun 17, 2025 | Zhao Baiteng | Director | Grant(A) | 40K | — | $0 |
| Jun 12, 2025 | Avoro Ventures LLC | Director, 10% Owner | Grant(A) | 40K | — | $0 |
| Jun 12, 2025 | Dalal Anupam | Director | Grant(A) | 40K | — | $0 |
| Jun 12, 2025 | Castelein Caley | Director | Grant(A) | 40K | — | $0 |
| Jun 12, 2025 | Reeve Emma | Director | Grant(A) | 40K | — | $0 |
| Jun 12, 2025 | Maroun Richard E | Director | Grant(A) | 40K | — | $0 |
| Jun 12, 2025 | Hirmand Mohammad | Director | Grant(A) | 40K | — | $0 |
| Jun 12, 2025 | Desai Neil | Director | Grant(A) | 40K | — | $0 |
| Apr 1, 2025 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 776K | — | $0 |
| Apr 1, 2025 | Lennon David James | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 776K | — | $0 |
| Apr 1, 2025 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Grant(A) | 474K | — | $0 |
| Apr 1, 2025 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Grant(A) | 474K | — | $0 |
| Apr 1, 2025 | Ball Bryan | See remarks | Grant(A) | 367K | — | $0 |
| Apr 1, 2025 | Ball Bryan | See remarks | Grant(A) | 367K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).